Viewing Study NCT03291158


Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-04-14 @ 9:41 AM
Study NCT ID: NCT03291158
Status: WITHDRAWN
Last Update Posted: 2023-09-21
First Post: 2017-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module